banner
Dehydrogenase inhibitor, 3-Nitropropanoic acid, Purity ≥98%
Inquiry

Cat. No.: X24-09-YM223

Dehydrogenase inhibitor, 3-Nitropropanoic acid, Purity ≥98%

Synonym: 504-88-1; β-Nitropropionic acid; Bovinocidin; 3-Nitropropanoic acid; Dehydrogenase inhibitor

  • MDL: MFCD00007406
  • CAS Number: 504-88-1
  • Compound CID: 1678
img
Product Size
100 mg; 200 mg; 500 mg; 1 g
Price
Datasheet
MSDS
Properties
Description
3-Nitropropanoic acid is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting dehydrogenases. The molecular weight of the compound is 119.08, and its molecular formula is C3H5NO4.
Molecular Weight
119.08
Molecular Formula
C3H5NO4
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
3-Nitropropanoic acid can be studied extensively for its potential therapeutic applications in the treatment of neurodegenerative diseases, particularly Huntington’s disease.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0